It might be time to see the light – low-level and intense pulsed light, that is – when it comes to dry eye and ocular surface disease treatments. A growing base of evidence suggests that low-level light therapy (LLLT) and intense pulsed light (IPL) therapy, like Espansione Group’s Light Modulation® (LM®) LLLT and Optimal Power Energy® (OPE®) are a big part of the future treatment paradigm for these diseases and more.
In this full recording of two booth talks at ESCRS 2023, Professor Giuseppe Giancare and Sarah Farrant explore the growing body of research on light therapy and their tantalizing prospects in the future of dry eye, cataract & refractive surgery and OSD treatments. So check out the full talks and head over to Espansione’s website at https://espansionegroup.it/ for more details!
